Imbrave150 Trial Frontline Treatment Of Advanced Hcc

Summary

The role of sorafenib in the first-line Peter R. Galle, MD, PhD, Johannes Gutenberg University, Mainz, Germany, shares updated efficacy data from the Phase III ... James J. Harding, MD, regional director of Early Drug Development at Memorial Sloan Kettering Cancer Center, discusses the ... Daneng Li, MD, discusses the subgroup analysis of the phase 3 Richard S. Finn, MD, discusses the significance of the results presented on the recent Daneng Li, MD, of City of Hope National Medical Center, Duarte, CA, discusses results from older adults enrolled in Dr. Finn, Professor, Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine, Director, Signal ... A Division of Liver Medicine Grand Rounds presented by Josep Llovet, MD, Professor of Medicine (Liver Diseases), Director, ... Center, distinguishes between lenvatinib and sorafenib for the